Company intelligence
Ivy Tree Advisors
Management and Strategy Consulting for HealthTech and Biopharma
About Ivy Tree Advisors
Ivy Tree Advisors is a network consultancy of 30+ consultants from the world's top companies and successful health ventures who possess deep expertise and a successful track record. We routinely perform and execute market entry strategy, commercialization, and product launch for both health tech ventures and large established organizations seeking to innovate and grow. We help drive traction for innovative products in pharmaceuticals, health tech, and technology. Exceptional results come from smart product planning and execution tailored to your market.
Verified activity
Signals from Ivy Tree Advisors
2 published signals
Customers & Market
Ivy Tree Advisors reported that Boehringer Ingelheim moved at a pace that shows it in 2026 AI activity, including signing four significant AI discovery partnerships in 2026 and investing £150 million over ten years to open a new AI accelerator in London’s Knowledge Quarter.
Reported by Jonathan Olsen, MBA
Partnerships
Ivy Tree Advisors announced Merck's $1 billion Google Cloud partnership spanning all of Merck's functions including R&D, manufacturing, commercial, and corporate.
Reported by Jonathan Olsen, MBA